EUS引导下凝血酶注射联合弹簧圈置入治疗胃静脉曲张的可行性、安全性与结局
该回顾性研究纳入2015年10月至2020年2月接受EUS引导下弹簧圈联合凝血酶治疗胃静脉曲张的20例患者,共33次操作。技术成功19例(95%),随访中17例(85%)曲张静脉血流闭塞,6周生存率100%,2例再出血均经内镜处理。结论认为该联合治疗技术安全且中期疗效良好。
要点
- EUS引导下弹簧圈联合凝血酶治疗胃静脉曲张技术成功率高(95%),血流闭塞率85%。
- 6周生存率100%,再出血事件少且均可经内镜处理。
- 需多中心随机对照试验比较不同治疗策略以优化选择。
核心结论
- EUS引导下弹簧圈联合凝血酶闭塞胃静脉曲张技术安全,中期疗效良好。
研究设计与样本
- 回顾性研究,纳入2015年10月至2020年2月接受EUS引导下弹簧圈联合凝血酶治疗的20例胃静脉曲张患者,共33次操作。
主要发现
- 20例中16例(80%)为1型孤立胃静脉曲张,4例为2型胃食管静脉曲张。
- 中位随访842天(IQR 483-961),17例(85%)有肝硬化,中位Child-Pugh评分6(IQR 5-7)。
- 11例(55%)为二级预防,2例(10%)为急性出血。
- 技术成功19例(95%),随访中17例(85%)曲张静脉血流闭塞。
- 6周生存率100%,2例再出血(第5天和第37天)均经内镜成功处理。
临床怎么用
- 对于胃静脉曲张患者,EUS引导下弹簧圈联合凝血酶可作为二级预防或急性出血管理的可选方案。
局限性
- 回顾性设计,样本量小(20例),来自单中心经验,需多中心随机对照试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Gastric varices (GVs) are reported in up to 20% of patients with portal hypertension, and bleeding is often more severe and challenging than esophageal variceal bleeding. Data are limited on prophylaxis of GV bleeding or management in the acute setting, and different techniques are used. This study evaluated outcomes after EUS-guided placement of coils in combination with thrombin to manage GVs. METHODS: We retrospectively reviewed all patients treated with combination EUS-guided therapy with coils and thrombin between October 2015 and February 2020. RESULTS: Twenty patients underwent 33 procedures for GV therapy; 16 of 20 (80%) had type 1 isolated GVs and 4 patients had type 2 gastroesophageal varices. The median follow-up was 842 days (interquartile range [IQR], 483-961). Seventeen patients (85%) had underlying cirrhosis, the most common etiologies being alcohol-related liver disease and nonalcoholic steatohepatitis. The median Child-Pugh score was 6 (IQR, 5-7). In 11 patients (55%), the indication was secondary prophylaxis to prevent recurrent bleeding; in 2 of 20 patients (10%), the bleeding was acute. Technical success was achieved in 19 patients (95%). During follow-up, the obliteration of flow within the varices was achieved in 17 patients (85%). The 6-week survival rate was 100%, and 2 adverse events, recurrent bleeding at day 5 and at day 37, were reported; both recurrent bleeding events were successfully managed endoscopically. CONCLUSIONS: EUS-guided GV obliteration combining coil placement with thrombin, in our experience, was technically safe with good medium-term efficacy. A multicenter randomized controlled trial comparing different treatment strategies is desirable to understand options better.
引用
- O'Rourke J, Todd A, Shekhar C, et al. EUS-guided thrombin injection and coil implantation for gastric varices: feasibility, safety, and outcomes. Gastrointest Endosc. 2024. PMID: 38316226. doi:10.1016/j.gie.2024.01.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。